文献速递自身免疫性与大疱性皮肤病

大疱性类天疱疮疾病面积指数严重度评分的国际验证及轻中重度界值计算

International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid.
PubMed 文献 · Br J Dermatol · 2020-11-29

该研究基于欧洲50个皮肤科285例大疱性类天疱疮患者,由两名盲法研究者记录BPDAI评分,以BPDAI评分的第25和75百分位计算界值。

要点

  • BPDAI界值:轻度≤19,中度20–56,重度≥57。
  • BPDAI改善与抗BP180抗体绝对下降相关,与抗BP230无关。

核心结论

  • 研究提示BPDAI界值20–57可区分轻、中、重度大疱性类天疱疮,并确认BPDAI是精确评估病情的稳健工具。

研究设计与样本

  • 研究纳入欧洲50个皮肤科285例大疱性类天疱疮患者,由两名盲法研究者记录严重度评分,并用ELISA检测抗BP180和抗BP230抗体。
  • 轻、中、重度界值基于BPDAI评分的第25和75百分位计算。

主要发现

  • BPDAI评分第25和75百分位分别为20和57。
  • 每日新发水疱≤10个的患者BPDAI中位数为26(IQR 17–45),>10个的患者中位数为55(IQR 39–82)。

关键数值与推荐

  • 轻度大疱性类天疱疮定义为BPDAI≤19。
  • 中度大疱性类天疱疮定义为BPDAI≥20且≤56。
  • 重度大疱性类天疱疮定义为BPDAI≥57。

临床怎么用

  • 临床可用BPDAI界值≤19、20–56、≥57将大疱性类天疱疮分为轻、中、重度以辅助病情评估。
  • BPDAI信度高且与抗BP180抗体变化相关,可用于纵向监测病情活动度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Bullous Pemphigoid Disease Area Index (BPDAI) score has been proposed to provide an objective measure of bullous pemphigoid (BP) activity. OBJECTIVES: The objective of this study was to calculate BPDAI cut-off values defining mild, moderate and severe BP. We also aimed to assess the interrater reliability and correlation with the number of daily new blisters, and anti-BP180 and anti-BP230 antibodies. METHODS: Severity scores were recorded by two blinded investigators. Anti-BP180 and anti-BP230 antibodies were measured using an enzyme-linked immunosorbent assay (ELISA). Cut-off values defining mild, moderate and severe subgroups were calculated based on the 25th and 75th percentiles of the BPDAI score. RESULTS: In total, 285 patients with BP were enrolled from 50 dermatology departments in Europe. Median BPDAI activity was 37·5 points (range 0-164). Cut-off values corresponding to the first and third quartiles of the BPDAI score were 20 and 57, respectively; thus, these values were used to define mild (≤ 19), moderate (≥ 20 and ≤ 56) and severe (≥ 57) BP. The median BPDAI score for patients with ≤ 10 daily new blisters was 26 [interquartile range (IQR) 17-45], and for patients with > 10 daily new blisters the median score was 55 (IQR 39-82). The BPDAI intraclass correlation coefficient measured at baseline was 0·97 and remained higher than 0·90 up to month 6. The improvement in the BPDAI score was correlated with the absolute decrease in anti-BP180 ELISA value (Spearman's rank r = 0·34, P < 0·004), but not with anti-BP230 antibodies (r = 0·17, P = 0·15). CONCLUSIONS: This study suggests cut-off values of 20-57 for BPDAI to distinguish mild, moderate and severe BP, and confirms that it is a robust tool to assess BP severity precisely.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Masmoudi W, Vaillant M, Vassileva S, et al. International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid. Br J Dermatol. 2020. PMID: 33067805. doi:10.1111/bjd.19611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。